Welcome to the Investor Centre
Latest videos
-
AGH July 4C 2022
Click here to view -
AGH Europe Expansion in Ireland
Click here to view -
AGH Half Year 2021
Click here to view
Althea Group Holdings is a global leader in the manufacturing, sales and distribution of cannabis-based medicines and recreational cannabis products.
AGH services these sectors via two distinct strategic business units. Althea, the company's pharmaceutical business, offers a comprehensive range of cannabis-based medicines which are made available to patients via prescription. Peak Processing Solutions, AGH's recreational cannabis business, produces legal cannabis products purchased by adult consumers in retail stores. AGH operates in highly regulated cannabis markets across the world with burgeoning operations in Europe, North America, Australia and Africa.
ASX Announcements
-
Althea Announces Distribution Agreement With Symbion
Click here to view -
Althea To Distribute Vessel Branded Vape Pens
Click here to view -
AGH Organisational Review Update
Click here to view -
Issue of Shares and Performance Rights
Click here to view -
Notification regarding unquoted securities - AGH
Click here to view -
Application for quotation of securities - AGH
Click here to view -
Becoming a substantial holder
Click here to view -
Germany Approves the Legalisation of Recreational Cannabis
Click here to view -
France to Legalise Medicinal Cannabis Extracts
Click here to view -
Half Yearly Report and Accounts
Click here to view -
Peak Signs Agreement with Collective Project
Click here to view -
Results of Meeting
Click here to view -
Quarterly Activities/Appendix 4C Cash Flow Report
Click here to view -
Alteration to Notice of Meeting
Click here to view -
Althea Launches THC Softgel Capsule Range
Click here to view -
Notice of Annual General Meeting/Proxy Form
Click here to view
-
AGH Completes AUD$5.32m Sale and Leaseback
Click here to view -
Althea THC20CBD1 Approved For Reimbursement In Ireland
Click here to view -
Sale and Leaseback Agreement to Raise CAD$4.6m (AUD$5.32m)
Click here to view -
Quarterly Activities/Appendix 4C Cash Flow Report
Click here to view -
Cleansing Notice
Click here to view -
Application for quotation of securities - AGH
Click here to view -
Application for quotation of securities - AGH
Click here to view -
Change of Director's Interest Notice
Click here to view -
Change of Director's Interest Notice
Click here to view -
Change of Director's Interest Notice
Click here to view -
Proposed issue of securities - AGH
Click here to view -
Appendix 4G and Corporate Governance Statement
Click here to view -
Annual Report to Shareholders
Click here to view -
Results of Meeting
Click here to view -
Peaks Signs Contract Extension With Electric Brands Inc
Click here to view -
Cleansing Notice
Click here to view -
Application for quotation of securities - AGH
Click here to view -
Althea CBD12 THC10 Approved for Reimbursement in Ireland
Click here to view -
Peaks Signs Contract Manufacturing Agreement with Tweed Inc
Click here to view -
Notice of Extraordinary General Meeting/Proxy Form
Click here to view -
Quarterly Activities/Appendix 4C Cash Flow Report
Click here to view -
Cleansing Notice
Click here to view -
Application for quotation of securities - AGH
Click here to view -
Althea THC20 CBD1 Approved For Sale In Ireland
Click here to view -
NHS Reimbursement Achieved for Treatment of Chronic Pain
Click here to view
-
Application for quotation of securities - AGH
Click here to view -
Results of Share Purchase Plan Offer
Click here to view -
Share Purchase Plan - Closing Date Extended
Click here to view -
Results of Meeting
Click here to view -
CEO Address To Shareholders
Click here to view -
Cleansing Notice
Click here to view -
Application for quotation of securities - AGH
Click here to view -
Althea Signs MOU with Dr Reddys Subsidiary
Click here to view -
Change in substantial holding
Click here to view -
Share Purchase Plan Offer Document
Click here to view -
Notice of Annual General Meeting/Proxy Form
Click here to view -
Proposed issue of securities - AGH
Click here to view -
Proposed issue of securities - AGH
Click here to view -
Reinstatement to Official Quotation
Click here to view -
AGH Announces Capital Raising to Support Ongoing Growth
Click here to view -
Voluntary Suspension
Click here to view -
Monthly Activities/Appendix 4C Cash Flow Report
Click here to view -
Trading Halt
Click here to view -
Application for quotation of securities - AGH
Click here to view -
Investor Webinar Details
Click here to view -
Althea Launches Next Generation Products
Click here to view -
Investor Presentation
Click here to view -
Annual Report to Shareholders
Click here to view -
Appendix 4G and Corporate Governance Statement
Click here to view -
Quarterly Activities/Appendix 4C Cash Flow Report
Click here to view
-
Results of Meeting
Click here to view -
CEO's Address To Shareholders
Click here to view -
Notification regarding unquoted securities - AGH
Click here to view -
Issuing of Securities
Click here to view -
Notification regarding unquoted securities - AGH
Click here to view -
Application for quotation of securities - AGH
Click here to view -
Notice of Annual General Meeting And Proxy Form
Click here to view -
Jobkeeper Payments
Click here to view -
Statement Pursuant to Listing Rule 4.7C.3
Click here to view -
Quarterly Activities/Appendix 4C Cash Flow Report
Click here to view -
Becoming a substantial holder
Click here to view -
Cleansing Notice
Click here to view -
Application for quotation of securities - AGH
Click here to view -
Peak Signs USD$3.42m Agreement With The Boston Beer Company
Click here to view -
Appendix 4G and Corporate Governance Statement
Click here to view -
Annual Report to Shareholders
Click here to view -
Response to ASX Query
Click here to view -
Proposed issue of securities - AGH
Click here to view -
AGH Successfully Raises $10.64m To Fuel Growth & Expansion
Click here to view -
Peak Signs With Canopy Growth Subsidiary and Trading Update
Click here to view -
Trading Halt
Click here to view -
Quarterly Activities/Appendix 4C Cash Flow Report
Click here to view -
Investor Presentation
Click here to view -
Peak signs CAD$1.25M contract with 48North Cannabis Corp
Click here to view -
Clarification Regarding ASX Announcement of 23 June 2021
Click here to view
-
Appendix 2A
Click here to view -
Supply and Distribution Agreement for UK and Jersey
Click here to view -
Share Purchase Plan Offer Document
Click here to view -
Cleansing Notice
Click here to view -
Appendix 2A
Click here to view -
CBD Medicines Available For Over-The-Counter Sale From 2021
Click here to view -
Investor Presentation
Click here to view -
Proposed issue of Securities - AGH
Click here to view -
Althea Announces Capital Raising to Support Ongoing Growth
Click here to view -
Trading Halt
Click here to view -
Strong UK Sales Combine For Record Revenue In November
Click here to view -
Althea Expands Into South Africa With New Supply Agreement
Click here to view -
Peak To Manufacture US Cannabis Brand Tinleys In Canada
Click here to view -
Results of Meeting
Click here to view -
CEO's Address To Shareholders
Click here to view -
Investor Webinar on Peaks Fast Start Readying for Germany
Click here to view -
Althea Products Approved for Sale in Germany
Click here to view -
Peak Lifts Expected Revenue With Two New Agreements
Click here to view -
Appendix 2A and Appendix 3G
Click here to view -
Cleansing Notice
Click here to view -
Corporate Governance Statement
Click here to view -
Notice of Annual General Meeting/Proxy Form
Click here to view -
Appendix 4C - quarterly
Click here to view -
Ceasing to be a substantial holder
Click here to view -
Appendix 2A
Click here to view
-
Whistleblower Policy
Click here to view -
Althea approaching 4,000 patients in Australia
Click here to view -
Results of Meeting
Click here to view -
2019 AGM CEO Address
Click here to view -
Althea Passes 3,000 Patient Milestone
Click here to view -
MyAccess Clinics Secures Licence with UK Health Regulator
Click here to view -
Althea to Supply Product for Clinical Trial
Click here to view -
Althea Commences German Market Entry
Click here to view -
Notice of Annual General Meeting/Proxy Form
Click here to view -
Becoming a substantial holder from PDL
Click here to view -
Althea Launches New Full Spectrum CBD Product
Click here to view -
Change in substantial holding
Click here to view -
Change of Director's Interest Notice
Click here to view -
Change of Director's Interest Notice
Click here to view -
Change of Director's Interest Notice
Click here to view -
Althea Extends Product Supply Agreement Until 2027
Click here to view -
Trading Halt
Click here to view -
Pause in Trading
Click here to view -
Change of Director's Interest Notice
Click here to view -
Change of Director's Interest Notice
Click here to view -
Appendix 3B
Click here to view -
Cleansing Notice
Click here to view -
Althea Completes Acquisition of Peak Processing Solutions
Click here to view -
Appendix 4C, Market Update and Peak Processing LOI
Click here to view -
Results of Meeting
Click here to view
-
Althea receives largest shipment of inventory
Click here to view -
Investor Presentation - December 2018
Click here to view -
Initial Director's Interest Notice
Click here to view -
Results of Meeting
Click here to view -
CEO Address to Shareholders
Click here to view -
Change of Director's Interest Notice
Click here to view -
Althea granted Export Licence
Click here to view -
Althea granted Manufacture Licence
Click here to view -
Notice of Annual General Meeting/Proxy Form
Click here to view -
Appendix 4C - quarterly
Click here to view -
Althea reaches 100 patients
Click here to view -
Althea appoints cannabis distributor
Click here to view -
Althea appoints Chief Financial Officer and General Counsel
Click here to view -
Becoming a substantial holder
Click here to view -
Becoming a substantial holder
Click here to view -
Becoming a substantial holder
Click here to view -
Becoming a substantial holder
Click here to view -
Initial Director's Interest Notice
Click here to view -
Initial Director's Interest Notice
Click here to view -
Initial Director's Interest Notice
Click here to view -
Initial Director's Interest Notice
Click here to view -
Althea completes fund raising for ASX IPO
Click here to view -
Securities Dealing Policy
Click here to view -
Long Term Incentive Plan
Click here to view -
Audited FY2018 Accounts- Althea Company Pty Ltd
Click here to view
News Releases
-
Althea Group Holdings unveils new corporate branding and website
Click here to view
-
Althea signs medicinal cannabis supply agreement with UK’s Grow Pharma
Click here to view -
UK Government announces faster access to cannabis-based medicines in watershed moment for Althea UK
Click here to view -
Althea shares almost triple on the cannabis company’s ASX debut
Click here to view
Financial Reports
-
Half-Year Financial Report – 31 Dec 2023
Click here to view
-
Annual Financial Report – 30 June 2023
Click here to view -
Half-Year Financial Report - 31 Dec 2022
Click here to view
-
Annual Financial Report – 30 June 2022
Click here to view -
Half-Year Financial Report - 31 Dec 2021
Click here to view
-
Annual Financial Report – 30 June 2021
Click here to view -
Half-Year Financial Report – 31 Dec 2020
Click here to view
-
Annual Financial Report – 30 June 2020
Click here to view -
Half-Year Financial Report – 31 Dec 2019
Click here to view
-
Annual Financial Report – 30 June 2019
Click here to view -
Half-Year Financial Report - 31 Dec 2018
Click here to view -
Appendix 4D
Click here to view
Althea Live Share Statistics